# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-333920
Filing Date
2026-08-05
Accepted
2026-08-05 08:10:38
Documents
60
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ima-20260630.htm iXBRL | 10-Q | 2804650
2 | EX-31.1 | ima-ex31_1.htm | EX-31.1 | 17909
3 | EX-31.2 | ima-ex31_2.htm | EX-31.2 | 17797
4 | EX-32.1 | ima-ex32_1.htm | EX-32.1 | 18566
| Complete submission text file | 0001193125-26-333920.txt |  | 9441652

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ima-20260630.xsd | EX-101.SCH | 1173653
64 | EXTRACTED XBRL INSTANCE DOCUMENT | ima-20260630_htm.xml | XML | 1468244

Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 261241422
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)